Asembia: 2019 Specialty Pharmacy Summit
2019 Specialty Pharmacy Summit At-A-Glance:
Weighing Cost Effectiveness for Biomarker Utilization in Immunotherapy
Researchers recently discussed the costs and benefits of utilizing immunotherapy biomarkers to better target immune checkpoint inhibitors in cancer patients.
Specialty Pharmacy’s Role in Advancing Treatments for Inflammatory Bowel Disease
Researchers recently spoke about the role specialty pharmacy plays in developing innovative, cost-effective treatments for patients with inflammatory bowel disease.
Costs, Payer Considerations for Hereditary ATTR Amyloidosis, Rare Disease Treatment
Sami Khella, MD, and Karen Thomas PharmD, PhD, recently discussed current and emerging therapies for hereditary ATTR Amyloidosis treatment and highlighted ways payers can effectively manage rare diseases.
Importance of Identifying Alzheimer Disease Early
Maria Shriver recently spoke at the Asembia 2019 Specialty Pharmacy Summit and explained why it is important to diagnose and identify Alzheimer disease, particularly among women.
Scott Gottlieb, MD, Discusses Time Spent at FDA, Comments on Future of Agency
Scott Gottlieb, MD, recently spoke about progress made during his tenure as FDA Commissioner, projects that are still underway and require more work, and discussed the future of the agency.
Importance of Collaborating With Specialty Pharmacy to Improve Patient Care
Rina Shah, divisional vice president of Pharmacy Operations and Specialty at Walgreens and LeeAnn Mengel, vice president of Baptist MD Anderson Cancer Center, explained how their recent partnership has improved patient outcomes and provided a better understanding of formulary and payer dynamics among the entire health care team.
Are Copay Accumulator Programs Helping Manage Costs or Limiting Patient Access?
Bruce Feinberg, DO, vice president and chief medical officer at Cardinal Health Specialty Solutions, recently discussed barriers and benefits of copay accumulator programs for the patient, provider, and payers.
How the Changing Technology Landscape in Health Care Can Improve Patient Care
James Adams of AllianceRx Walgreens Prime, and Sean Creehan of Inovalon, recently discussed the importance of cloud-based technology use within the health care sector and explained how this technology can bring value to payers as well as improve patient outcomes.
Understanding Costs, Patient Outcomes Associated With PCSK9 Inhibitor Use
During a session at the Asembia 2019 Specialty Summit, Rhonda Cooper-DeHoff, PharmD, and Joseph Saseen, PharmD, reviewed recent clinical data for PCSK9 inhibitors and analyzed recent cost-effectiveness data.
Weighing Treatment Options for CIPD
Researchers recently presented information pertaining to the diagnosis and treatment of a rare nerve disorder that can cause paralysis through the use of immunoglobulin therapy.
Featured Session: Specialty Pharmacy Industry Outlook: What’s Next?
In this thought-provoking Featured Session, hear from three of the industry’s top experts as they update their analysis and outlook on our dynamic industry.
Evaluating and Comparing Treatment Outcomes in Specialty Care
Attendees will learn about the outcomes measures used, and how they were defined, and hear the results from this multi-hospital pilot.
Copay Accumulator Programs: Effective Tool for Managing Costs or Barrier to Patient Access?
In this session, Dr Feinberg will explore both sides of the debate.
Transforming Specialty Pharmacy Operations to Deliver Better Patient Care
In this session, presenters will describe how cloud-based technology is being leveraged to connect various parts of the health care delivery matrix and provide patients living with complex, chronic illnesses with more holistic care and improved outcomes.
Market Disintermediation: Mergers, Mega Players and Media Hype
In this session, Mr Erhardt discusses the ongoing market changes and how these might impact the strategies of manufacturers as they look at their marketing and commercialization options.
Real-Time Benefit Check: The Next Revolution in Healthcare
In this session, the speakers will examine how RTBC may help reduce medication abandonment, improve medication adherence and outcomes, and enhance patient and provider satisfaction.
Keynote Speaker: Maria Shriver
A trailblazer for empowering women and one of the world’s leading advocates for women and Alzheimer’s disease, Maria Shriver serves as an inspiration for others to become “Architects of Change” and make the world a better place.
Savor the Moment: Dining at Wynn Las Vegas and Encore Resorts
Wynn Las Vegas and Encore Resorts offer award-winning restaurants, exciting entertainment, and nightlife to enhance your stay.
Enjoy the Show: Concerts, Shows, and Entertainment at Wynn Las Vegas and Encore Resorts
Wynn Las Vegas and Encore Resorts offer visitors a myriad of experiences that promise to amaze and entertain.
